Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intervertebral Disc | 11 | 2020 | 114 | 1.310 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2023 | 67 | 0.780 |
Why?
|
| Annulus Fibrosus | 3 | 2017 | 4 | 0.770 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 164 | 0.750 |
Why?
|
| Chondrocytes | 2 | 2019 | 92 | 0.700 |
Why?
|
| Interleukin-4 | 1 | 2019 | 17 | 0.610 |
Why?
|
| Intervertebral Disc Degeneration | 5 | 2020 | 74 | 0.580 |
Why?
|
| Cell Movement | 2 | 2020 | 73 | 0.550 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 13 | 0.520 |
Why?
|
| Cells, Cultured | 8 | 2019 | 463 | 0.490 |
Why?
|
| Rabbits | 8 | 2023 | 163 | 0.430 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 31 | 0.410 |
Why?
|
| Contrast Media | 1 | 2013 | 59 | 0.410 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 71 | 0.400 |
Why?
|
| Apoptosis | 1 | 2013 | 180 | 0.390 |
Why?
|
| Animals | 12 | 2023 | 3255 | 0.380 |
Why?
|
| Inflammation | 4 | 2023 | 226 | 0.360 |
Why?
|
| Microspheres | 2 | 2023 | 24 | 0.300 |
Why?
|
| Nucleus Pulposus | 2 | 2016 | 5 | 0.250 |
Why?
|
| Brassica | 1 | 2023 | 1 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 231 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 30 | 0.200 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2023 | 6 | 0.200 |
Why?
|
| Hydrogels | 1 | 2023 | 7 | 0.200 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 26 | 0.200 |
Why?
|
| Microbiota | 1 | 2023 | 65 | 0.200 |
Why?
|
| Pilot Projects | 1 | 2023 | 370 | 0.180 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 124 | 0.180 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2019 | 1 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 11 | 0.150 |
Why?
|
| Interleukin-8 | 2 | 2016 | 14 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2018 | 49 | 0.140 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 36 | 0.140 |
Why?
|
| Collagen Type II | 2 | 2018 | 18 | 0.140 |
Why?
|
| Humans | 10 | 2023 | 22823 | 0.130 |
Why?
|
| Cattle | 2 | 2014 | 110 | 0.130 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 153 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 312 | 0.130 |
Why?
|
| Biglycan | 1 | 2016 | 5 | 0.130 |
Why?
|
| Sensory System Agents | 1 | 2016 | 2 | 0.130 |
Why?
|
| Substance P | 1 | 2016 | 10 | 0.130 |
Why?
|
| Capsaicin | 1 | 2016 | 8 | 0.130 |
Why?
|
| Interleukins | 1 | 2016 | 21 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 4 | 0.120 |
Why?
|
| Amides | 1 | 2016 | 15 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 26 | 0.120 |
Why?
|
| Back Pain | 1 | 2016 | 52 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 202 | 0.120 |
Why?
|
| Cell Transplantation | 2 | 2015 | 15 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2015 | 28 | 0.120 |
Why?
|
| Fibronectins | 1 | 2015 | 17 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2017 | 390 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 2014 | 44 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2014 | 37 | 0.110 |
Why?
|
| Menisci, Tibial | 1 | 2015 | 93 | 0.110 |
Why?
|
| Neurons | 1 | 2016 | 273 | 0.110 |
Why?
|
| Intervertebral Disc Displacement | 2 | 2013 | 74 | 0.110 |
Why?
|
| Iopamidol | 1 | 2013 | 1 | 0.100 |
Why?
|
| Iohexol | 1 | 2013 | 2 | 0.100 |
Why?
|
| Lidocaine | 1 | 2013 | 20 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 103 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2013 | 39 | 0.100 |
Why?
|
| Cell Survival | 1 | 2013 | 94 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 27 | 0.100 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 253 | 0.090 |
Why?
|
| Spine | 1 | 2013 | 98 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 295 | 0.090 |
Why?
|
| Proteins | 1 | 2011 | 51 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 33 | 0.080 |
Why?
|
| Biological Products | 1 | 2011 | 31 | 0.080 |
Why?
|
| Bone Regeneration | 1 | 2011 | 68 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2011 | 83 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2013 | 225 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1258 | 0.080 |
Why?
|
| Spinal Diseases | 1 | 2011 | 106 | 0.080 |
Why?
|
| Proteoglycans | 2 | 2018 | 117 | 0.060 |
Why?
|
| Mice | 2 | 2023 | 1228 | 0.060 |
Why?
|
| Gene Expression | 2 | 2016 | 175 | 0.050 |
Why?
|
| Seedlings | 1 | 2023 | 4 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2016 | 156 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 20 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2023 | 12 | 0.050 |
Why?
|
| Bacteria | 1 | 2023 | 61 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 54 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 41 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 439 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 517 | 0.040 |
Why?
|
| Pain | 1 | 2023 | 326 | 0.040 |
Why?
|
| Receptors, CCR1 | 1 | 2020 | 1 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2020 | 3 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 20 | 0.040 |
Why?
|
| Collagen | 1 | 2018 | 79 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2016 | 13 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 50 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 75 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 12 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 113 | 0.030 |
Why?
|
| Male | 3 | 2016 | 12400 | 0.030 |
Why?
|
| Female | 3 | 2016 | 12904 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 314 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 103 | 0.030 |
Why?
|
| Graft Survival | 1 | 2015 | 84 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 126 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2015 | 63 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 84 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 17 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2015 | 35 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2014 | 19 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 20 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2015 | 47 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 45 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 147 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 114 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 41 | 0.030 |
Why?
|
| Rats | 1 | 2016 | 623 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 228 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 64 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 186 | 0.030 |
Why?
|
| Adult | 2 | 2016 | 6896 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 271 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 323 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2014 | 276 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 7412 | 0.030 |
Why?
|
| Middle Aged | 2 | 2016 | 7873 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 7 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2013 | 11 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 14 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 66 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 1647 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 591 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 2934 | 0.010 |
Why?
|